Pluristem Expands its Compassionate Use Program: Treated First COVID-19 Patient in U.S. Under FDA Single Patient Expanded Access Program
Stock Information for Pluristem Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.